What to expect when you take Midodrine hydrochloride and have Systemic lupus erythematosus?

Do you take Midodrine hydrochloride and have Systemic lupus erythematosus? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Oct, 16, 2018

611 reports have been studied.


Females aged 50 to 59 :

391 related reports were analyzed:

Most common symptoms:

Abasia
  • 6.39% for females aged 50 (±5) who take Midodrine hydrochloride
Abdominal pain
  • 5.12% for females aged 50 (±5) who take Midodrine hydrochloride
Anaemia
  • 6.14% for females aged 50 (±5) who take Midodrine hydrochloride
Appetite - decreased
  • 8.7% for females aged 50 (±5) who take Midodrine hydrochloride
Atrial fibrillation/flutter
  • 9.97% for females aged 50 (±5) who take Midodrine hydrochloride
Bleeding disorders
  • 5.12% for females aged 50 (±5) who take Midodrine hydrochloride
Bone disorder
  • 8.7% for females aged 50 (±5) who take Midodrine hydrochloride
Cardiac failure congestive
  • 6.65% for females aged 50 (±5) who take Midodrine hydrochloride
Cellulitis
  • 7.16% for females aged 50 (±5) who take Midodrine hydrochloride
Deformity
  • 11.76% for females aged 50 (±5) who take Midodrine hydrochloride
Depression
  • 7.16% for females aged 50 (±5) who take Midodrine hydrochloride
Diarrhea
  • 6.14% for females aged 50 (±5) who take Midodrine hydrochloride
Dizziness
  • 10.49% for females aged 50 (±5) who take Midodrine hydrochloride
Dyspnea
  • 10.49% for females aged 50 (±5) who take Midodrine hydrochloride
Dyspnea exertional
  • 5.88% for females aged 50 (±5) who take Midodrine hydrochloride
Ejection fraction decreased
  • 5.12% for females aged 50 (±5) who take Midodrine hydrochloride
Enlarged heart
  • 6.65% for females aged 50 (±5) who take Midodrine hydrochloride
Fall
  • 8.18% for females aged 50 (±5) who take Midodrine hydrochloride
Fatigue
  • 8.95% for females aged 50 (±5) who take Midodrine hydrochloride
Fibrosis
  • 6.14% for females aged 50 (±5) who take Midodrine hydrochloride
Gait disturbance
  • 10.23% for females aged 50 (±5) who take Midodrine hydrochloride
General physical health deterioration
  • 5.63% for females aged 50 (±5) who take Midodrine hydrochloride
Headache
  • 7.42% for females aged 50 (±5) who take Midodrine hydrochloride
Hearing loss
  • 8.7% for females aged 50 (±5) who take Midodrine hydrochloride
High blood pressure
  • 5.88% for females aged 50 (±5) who take Midodrine hydrochloride
Hypoaesthesia
  • 7.42% for females aged 50 (±5) who take Midodrine hydrochloride
Hypotension
  • 11.76% for females aged 50 (±5) who take Midodrine hydrochloride
Indigestion
  • 5.37% for females aged 50 (±5) who take Midodrine hydrochloride
Infection
  • 9.21% for females aged 50 (±5) who take Midodrine hydrochloride
Injury
  • 5.12% for females aged 50 (±5) who take Midodrine hydrochloride
Jaw fracture
  • 8.7% for females aged 50 (±5) who take Midodrine hydrochloride
Joint dislocation
  • 5.37% for females aged 50 (±5) who take Midodrine hydrochloride
Joint pain
  • 12.28% for females aged 50 (±5) who take Midodrine hydrochloride
Joint range of motion decreased
  • 7.42% for females aged 50 (±5) who take Midodrine hydrochloride
Joint stiffness
  • 9.46% for females aged 50 (±5) who take Midodrine hydrochloride
Mobility decreased
  • 15.6% for females aged 50 (±5) who take Midodrine hydrochloride
Musculoskeletal stiffness
  • 7.16% for females aged 50 (±5) who take Midodrine hydrochloride
Nausea
  • 11.25% for females aged 50 (±5) who take Midodrine hydrochloride
Neck pain
  • 5.12% for females aged 50 (±5) who take Midodrine hydrochloride
Nephrogenic systemic fibrosis
  • 13.55% for females aged 50 (±5) who take Midodrine hydrochloride
Neuropathy peripheral
  • 8.95% for females aged 50 (±5) who take Midodrine hydrochloride
Oedema
  • 5.63% for females aged 50 (±5) who take Midodrine hydrochloride
Oedema peripheral
  • 14.83% for females aged 50 (±5) who take Midodrine hydrochloride
Orthostatic hypotension
  • 5.63% for females aged 50 (±5) who take Midodrine hydrochloride
Osteonecrosis of jaw
  • 7.16% for females aged 50 (±5) who take Midodrine hydrochloride
Pain
  • 23.02% for females aged 50 (±5) who take Midodrine hydrochloride
Pain in extremity
  • 14.58% for females aged 50 (±5) who take Midodrine hydrochloride
Pain in jaw
  • 5.63% for females aged 50 (±5) who take Midodrine hydrochloride
Paraesthesia
  • 6.14% for females aged 50 (±5) who take Midodrine hydrochloride
Pleural effusion
  • 6.14% for females aged 50 (±5) who take Midodrine hydrochloride
Pulmonary congestion
  • 5.37% for females aged 50 (±5) who take Midodrine hydrochloride
Pulmonary hypertension
  • 5.12% for females aged 50 (±5) who take Midodrine hydrochloride
Pulmonary oedema
  • 5.12% for females aged 50 (±5) who take Midodrine hydrochloride
Rashes
  • 9.46% for females aged 50 (±5) who take Midodrine hydrochloride
Renal failure chronic
  • 10.23% for females aged 50 (±5) who take Midodrine hydrochloride
Scar
  • 9.46% for females aged 50 (±5) who take Midodrine hydrochloride
Skin burning sensation
  • 5.88% for females aged 50 (±5) who take Midodrine hydrochloride
Skin exfoliation
  • 6.39% for females aged 50 (±5) who take Midodrine hydrochloride
Skin fibrosis
  • 8.95% for females aged 50 (±5) who take Midodrine hydrochloride
Skin hyperpigmentation
  • 11.0% for females aged 50 (±5) who take Midodrine hydrochloride
Skin hypertrophy
  • 9.72% for females aged 50 (±5) who take Midodrine hydrochloride
Skin induration
  • 10.74% for females aged 50 (±5) who take Midodrine hydrochloride
Skin plaque
  • 5.88% for females aged 50 (±5) who take Midodrine hydrochloride
Skin tightness
  • 9.46% for females aged 50 (±5) who take Midodrine hydrochloride
Spinal compression fracture
  • 5.37% for females aged 50 (±5) who take Midodrine hydrochloride
Stress and anxiety
  • 11.0% for females aged 50 (±5) who take Midodrine hydrochloride
Swallowing difficulty
  • 9.21% for females aged 50 (±5) who take Midodrine hydrochloride
Thrombocytopenia
  • 5.12% for females aged 50 (±5) who take Midodrine hydrochloride
Tooth abscess
  • 5.37% for females aged 50 (±5) who take Midodrine hydrochloride
Urinary tract infection
  • 7.67% for females aged 50 (±5) who take Midodrine hydrochloride
Weakness
  • 18.67% for females aged 50 (±5) who take Midodrine hydrochloride
Weight decreased
  • 11.51% for females aged 50 (±5) who take Midodrine hydrochloride

Most common co-existing conditions:

Depression
  • 7.93% for females aged 50 (±5) who take Midodrine hydrochloride
High blood cholesterol
  • 5.88% for females aged 50 (±5) who take Midodrine hydrochloride
Multiple myeloma
  • 7.93% for females aged 50 (±5) who take Midodrine hydrochloride
Nuclear magnetic resonance imaging brain
  • 7.16% for females aged 50 (±5) who take Midodrine hydrochloride
Orthostatic hypotension
  • 6.39% for females aged 50 (±5) who take Midodrine hydrochloride
Pain
  • 8.7% for females aged 50 (±5) who take Midodrine hydrochloride
Primary pulmonary hypertension
  • 5.37% for females aged 50 (±5) who take Midodrine hydrochloride
Stress and anxiety
  • 6.14% for females aged 50 (±5) who take Midodrine hydrochloride
back to top

Males aged 50 to 59 :

220 related reports were analyzed:

Most common symptoms:

Acute kidney failure
  • 8.64% for males aged 50 (±5) who take Midodrine hydrochloride
Arrhythmias
  • 7.73% for males aged 50 (±5) who take Midodrine hydrochloride
Cardiac failure congestive
  • 5.0% for males aged 50 (±5) who take Midodrine hydrochloride
Cardio-respiratory arrest
  • 5.91% for males aged 50 (±5) who take Midodrine hydrochloride
Chest pain
  • 6.82% for males aged 50 (±5) who take Midodrine hydrochloride
Diarrhea
  • 8.18% for males aged 50 (±5) who take Midodrine hydrochloride
Dizziness
  • 6.82% for males aged 50 (±5) who take Midodrine hydrochloride
Dyspnea
  • 10.91% for males aged 50 (±5) who take Midodrine hydrochloride
Fall
  • 5.91% for males aged 50 (±5) who take Midodrine hydrochloride
Fatigue
  • 7.27% for males aged 50 (±5) who take Midodrine hydrochloride
Gastrointestinal haemorrhage
  • 7.73% for males aged 50 (±5) who take Midodrine hydrochloride
Headache
  • 6.82% for males aged 50 (±5) who take Midodrine hydrochloride
Hepatic failure
  • 5.45% for males aged 50 (±5) who take Midodrine hydrochloride
High blood pressure
  • 5.0% for males aged 50 (±5) who take Midodrine hydrochloride
Hypotension
  • 16.82% for males aged 50 (±5) who take Midodrine hydrochloride
Nausea
  • 9.55% for males aged 50 (±5) who take Midodrine hydrochloride
Nausea and vomiting
  • 7.27% for males aged 50 (±5) who take Midodrine hydrochloride
Nephrogenic systemic fibrosis
  • 6.82% for males aged 50 (±5) who take Midodrine hydrochloride
Pain
  • 6.36% for males aged 50 (±5) who take Midodrine hydrochloride
Pneumonia
  • 10.45% for males aged 50 (±5) who take Midodrine hydrochloride
Renal failure acute
  • 5.45% for males aged 50 (±5) who take Midodrine hydrochloride
Sepsis
  • 7.27% for males aged 50 (±5) who take Midodrine hydrochloride
Septic shock
  • 5.45% for males aged 50 (±5) who take Midodrine hydrochloride
Stress and anxiety
  • 5.0% for males aged 50 (±5) who take Midodrine hydrochloride
Thrombocytopenia
  • 5.91% for males aged 50 (±5) who take Midodrine hydrochloride
Weakness
  • 6.82% for males aged 50 (±5) who take Midodrine hydrochloride

Most common co-existing conditions:

Multiple myeloma
  • 6.36% for males aged 50 (±5) who take Midodrine hydrochloride
Nuclear magnetic resonance imaging brain
  • 5.45% for males aged 50 (±5) who take Midodrine hydrochloride
Orthostatic hypotension
  • 5.0% for males aged 50 (±5) who take Midodrine hydrochloride
Pain
  • 6.82% for males aged 50 (±5) who take Midodrine hydrochloride
back to top

Do you take Midodrine hydrochloride and have Systemic lupus erythematosus:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

midodrine hydrochloride

Midodrine hydrochloride has active ingredients of midodrine hydrochloride. It is often used in hypotension. (latest outcomes from Midodrine hydrochloride 1,362 users)

systemic lupus erythematosus

Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) has been reported by people with rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, multiple sclerosis, osteoporosis (latest reports from 31,576 Systemic lupus erythematosus patients).

General study

Related publications that referenced our studies


Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.